Sign in

Private company

Sherlock Biosciences

American biotechnology company

Sherlock Biosciences was a biotechnology company based in Cambridge, Massachusetts that developed diagnostic tests using CRISPR-Cas13. The company was founded in 2019 by Feng Zhang, Jim Collins, Omar Abudayyeh, and Jonathan Gootenberg of the Broad Institute and MIT. Cas13 was discovered by teams led by Zhang and Eugene Koonin using computational methods, then further characterized by Jennifer Doudna's team at the University of California, Berkeley.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

  • Industrybiotechnology1
  • HeadquartersCambridge1

See how the biggest companies compare on our leaderboards

Sherlock Biosciences was a biotechnology company based in Cambridge, Massachusetts that developed diagnostic tests using CRISPR-Cas13. The company was founded in 2019 by Feng Zhang, Jim Collins, Omar Abudayyeh, and Jonathan Gootenberg of the Broad Institute and MIT. Cas13 was discovered by teams led by Zhang and Eugene Koonin using computational methods, then further characterized by Jennifer Doudna's team at the University of California, Berkeley.2

Corporate structure

Sherlock Biosciences is part of a group headed by ORASURE TECHNOLOGIES INC. 5 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • ORASURE TECHNOLOGIES INC Bethlehem, Pennsylvania
    • Sherlock Biosciences Cambridge
    • BioMedomics, Inc. Subsidiary · Delaware, United States
    • DNA Genotek Inc. Subsidiary · Canada
    • Sense Biodetection Limited Subsidiary · United Kingdom

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2